25 results
DEFR14A
ew6lr3za
12 May 22
Revised proxy
5:00pm
8-K
EX-14.1
qk6 7okrd7n
13 Dec 21
Arcturus Therapeutics Appoints Jing Marantz, M.D., Ph.D., M.B.A. to its Board of Directors
5:17pm
8-K
EX-1.1
fflfezps
8 Dec 20
Arcturus Therapeutics Announces Pricing of $150 Million Public Offering of Common Stock
9:01am
8-K
EX-1.1
alqw54 70oi
29 Jul 20
Arcturus Therapeutics Announces Pricing of $173.0 Million Public Offering of Common Stock
6:02am
8-K
EX-1.1
sq0z7n 5p6s4cj7
17 Apr 20
Entry into a Material Definitive Agreement
6:06am
8-K
EX-10.1
rftnomt
27 Mar 20
Entry into a Material Definitive Agreement
5:20pm
10-K
hib5577smo4 es8
16 Mar 20
Annual report
11:09am
8-K
EX-10.1
15360i4kn
27 Sep 19
Arcturus Therapeutics Announces $9.8 Million Registered Direct Offering of Common Stock
4:25pm
8-K
EX-10.1
iyyo k7jd
5 Aug 19
Arcturus Therapeutics Announces $2.3 Million Additional Registered Direct Offering of Common Stock
9:14am